TILT Holdings Announces New Brand Partnership with LEVEL to Bring Their Cannabis Tablets to Pennsylvania
PHOENIX, March 13, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT ) (OTCQB: TLLTF ), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced a new brand partnership to distribute LEVEL ’s targeted, effects-based infused tablets to patients in Pennsylvania.
- PHOENIX, March 13, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT ) (OTCQB: TLLTF ), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced a new brand partnership to distribute LEVEL ’s targeted, effects-based infused tablets to patients in Pennsylvania.
- “Partnering with LEVEL to bring their products to market in Pennsylvania expands TILT’s offerings in a meaningful way for medical patients.
- We love that these oral tablets are portable, discreet, and allow for dialed-in dosing.” said Tim Conder, Chief Executive Officer of TILT.
- Together, TILT and LEVEL are opening doors to forge new possibilities for medical cannabis consumers.”
“LEVEL is thrilled to bring a best-in-class, highly effective, long-lasting tablet to Pennsylvania through our partnership with TILT.